Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−35.28 CAD
−22.34 M CAD
6.07 M CAD
3.07 M
About COSCIENS BIOPHARMA INC
COSCIENS Biopharma Inc. Is a specialty biopharmaceutical company, which engages in the development and commercialization of diverse pharmaceutical and diagnostic products. The company is headquartered in Toronto, Canada.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 0UGB is 4.52 CAD — it has decreased by −10.34% in the past 24 hours. Watch COSCIENS BIOPHARMA INC COM NPV stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange COSCIENS BIOPHARMA INC COM NPV stocks are traded under the ticker 0UGB.
0UGB stock has fallen by −10.34% compared to the previous week, the month change is a −11.22% fall, over the last year COSCIENS BIOPHARMA INC COM NPV has showed a −99.44% decrease.
0UGB reached its all-time high on Feb 9, 2021 with the price of 1,336.00 CAD, and its all-time low was 4.52 CAD and was reached on Nov 12, 2024. View more price dynamics on 0UGB chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
0UGB stock is 11.53% volatile and has beta coefficient of 1.40. Track COSCIENS BIOPHARMA INC COM NPV stock price on the chart and check out the list of the most volatile stocks — is COSCIENS BIOPHARMA INC COM NPV there?
Today COSCIENS BIOPHARMA INC COM NPV has the market capitalization of 13.62 M, it has decreased by −5.19% over the last week.
Yes, you can track COSCIENS BIOPHARMA INC COM NPV financials in yearly and quarterly reports right on TradingView.
COSCIENS BIOPHARMA INC COM NPV is going to release the next earnings report on Apr 1, 2025. Keep track of upcoming events with our Earnings Calendar.
0UGB earnings for the last quarter are −2.50 CAD per share, whereas the estimation was −4.71 CAD resulting in a 46.84% surprise. The estimated earnings for the next quarter are −4.90 CAD per share. See more details about COSCIENS BIOPHARMA INC COM NPV earnings.
COSCIENS BIOPHARMA INC COM NPV revenue for the last quarter amounts to 2.57 M CAD, despite the estimated figure of 1.49 M CAD. In the next quarter, revenue is expected to reach 1.55 M CAD.
0UGB net income for the last quarter is −7.85 M CAD, while the quarter before that showed −1.95 M CAD of net income which accounts for −303.44% change. Track more COSCIENS BIOPHARMA INC COM NPV financial stats to get the full picture.
No, 0UGB doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 18, 2024, the company has 21.00 employees. See our rating of the largest employees — is COSCIENS BIOPHARMA INC COM NPV on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. COSCIENS BIOPHARMA INC COM NPV EBITDA is −27.40 M CAD, and current EBITDA margin is −396.60%. See more stats in COSCIENS BIOPHARMA INC COM NPV financial statements.
Like other stocks, 0UGB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade COSCIENS BIOPHARMA INC COM NPV stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So COSCIENS BIOPHARMA INC COM NPV technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating COSCIENS BIOPHARMA INC COM NPV stock shows the sell signal. See more of COSCIENS BIOPHARMA INC COM NPV technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.